Results 271 to 280 of about 1,622,414 (348)
Digital health technology use in clinical trials of rare diseases: a systematic review. [PDF]
Mao X +11 more
europepmc +1 more source
Background Relapsing polychondritis (RP) is a rare disease defined by recurrent cartilaginous inflammation. Anti‐collagen II (anti‐Col2) antibodies have been proposed as a diagnostic biomarker for RP, but their performance characteristics are not well defined.
Karyssa Stonick +6 more
wiley +1 more source
Orphan drugs: The final frontier in the fight against rare diseases.
Rajaram S, Medhi B.
europepmc +1 more source
Capability wellbeing of parents caring for children with rare diseases: a national cross-sectional study. [PDF]
Yu J +5 more
europepmc +1 more source
Institute Marseille Rare Diseases
openaire +1 more source
Objective The goal was to assess the diagnostic performance of three novel autoantibodies (NA) for Sjögren's disease (SjD) by comparing NA prevalence in patients with SjD, other autoimmune rheumatic diseases (ARDs), nonspecific chronic sialadenitis (CS), and controls.
Chadwick R. Johr +5 more
wiley +1 more source
The influence of professionals' personal views and values in the development of guidelines for rare diseases: an example from phenylketonuria. [PDF]
van Wegberg AMJ +2 more
europepmc +1 more source
Objective We developed a novel EHR sidecar application to visualize key rheumatoid arthritis (RA) outcomes, including disease activity, physical function, and pain, via a patient‐facing graphical interface designed for use during outpatient visits (“RA PRO dashboard”).
Gabriela Schmajuk +16 more
wiley +1 more source

